e-learning
resources
London 2016
Wednesday, 07.09.2016
Novel mechanisms and treatment modalities in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression
Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Ian Adcock, Fan Chung, Anthony Rowe, Christos Rossios, Ioannis Pandis, Ratko Djukanovich, Peter Sterk, Yike Guo, Coen Wiegman
Source:
International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Session:
Novel mechanisms and treatment modalities in asthma
Session type:
Poster Discussion
Number:
4897
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Ian Adcock, Fan Chung, Anthony Rowe, Christos Rossios, Ioannis Pandis, Ratko Djukanovich, Peter Sterk, Yike Guo, Coen Wiegman. Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression. Eur Respir J 2016; 48: Suppl. 60, 4897
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
MAPKAP kinase 2(MK2) expression is associated with severe asthma
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
Aerobic exercise reduces asthma phenotype by inhibition of JAK2, SOCS3 and STAT6 in airway epithelium and in peribronchial leukocytes
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
Low power laser (LBP) therapy downregulates the allergic lung inflammation in experimental asthma model: Effect driven to signal transducer and activator of transduction 6 (STAT-6)
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Systemic inhibition of p38 MAPK improves lung function and inflammatory markers in moderate-severe COPD
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Inhibition of inflammatory gene expression by dexamethasone partly depends on the phosphatase, MKP-1 (DUSP1)
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013
Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept